About Dylan Sammut
Articles Written by Dylan Sammut
Healthscope Divests Asia Pacific Healthcare Group
In an effort to refocus its business plan, Healthscope is selling Asia Pacific Healthcare Group (APHG), its New Zealand pathology business. With 25 laboratories, over 2,000 staff, and 150 collection centers throughout the country, APHG performed over 6.7 million... Read More »
IBH Population Health Expands With New Acquisition
IBH Population Health Solutions, a pioneer in managed behavioral health, integrated employee assistance programs (EAP) and services, announced a new acquisition this week. With the backing of Periscope Equity, the company added Claremont EAP for an undisclosed price,... Read More »
CRO M&A Market in 2020 (So Far)
There haven’t been many deals targeting contract research organizations (CRO) in 2020, especially compared to previous years, which makes sense. Life science companies are all slowing down clinical trials (COVID-19 vaccine research excluded) to adhere to social... Read More »
Ophthalmology Groups Are Still Selling
Despite the effects of COVID-19 on physician groups, investors are still acquiring ophthalmology groups, especially in the third quarter, according to DSO. Just last week, EyeSouth Partners acquired Retina Associates of Middle Georgia (RAMG) for an undisclosed sum.... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
